202 related articles for article (PubMed ID: 10686522)
21. Hypothalamic-pituitary cytokine network.
Kariagina A; Romanenko D; Ren SG; Chesnokova V
Endocrinology; 2004 Jan; 145(1):104-12. PubMed ID: 14512435
[TBL] [Abstract][Full Text] [Related]
22. Effects of repetitive administration of recombinant human interleukin-1 beta, an analog or corticotropin-releasing hormone combined with lysine vasopressin on rats with glucocorticoid-induced secondary adrenocortical insufficiency.
Murakami N; Fukata J; Usui T; Naito Y; Tominaga T; Nakai Y; Masui Y; Nakao K; Imura H
J Pharmacol Exp Ther; 1992 Mar; 260(3):1344-8. PubMed ID: 1312168
[TBL] [Abstract][Full Text] [Related]
23. Role of CRH in glucopenia-induced adrenomedullary activation in rats.
Goldstein DS; Garty M; Bagdy G; Szemeredi K; Sternberg EM; Listwak S; Pacak K; Deka-Starosta A; Hoffman A; Chang PC
J Neuroendocrinol; 1993 Oct; 5(5):475-86. PubMed ID: 8680414
[TBL] [Abstract][Full Text] [Related]
24. Characterization of an interleukin-6- and adrenocorticotropin-dependent, immune-to-adrenal pathway during viral infection.
Silverman MN; Miller AH; Biron CA; Pearce BD
Endocrinology; 2004 Aug; 145(8):3580-9. PubMed ID: 15044377
[TBL] [Abstract][Full Text] [Related]
25. Nitric oxide mediates the interleukin-1beta- and nicotine-induced hypothalamic-pituitary-adrenocortical response during social stress.
Gadek-Michalska A; Bugajski J
J Physiol Pharmacol; 2005 Sep; 56(3):491-503. PubMed ID: 16204770
[TBL] [Abstract][Full Text] [Related]
26. Enhanced endocrine response to novel environment stress and endotoxin in Lurcher mutant mice.
Frederic F; Chautard T; Brochard R; Chianale C; Wollman E; Oliver C; Delhaye-Bouchaud N; Mariani J
Neuroendocrinology; 1997 Nov; 66(5):341-7. PubMed ID: 9387853
[TBL] [Abstract][Full Text] [Related]
27. Chronic stress and pituitary-adrenocortical responses to corticotropin-releasing hormone and vasopressin in female pigs.
Janssens CJ; Helmond FA; Wiegant VM
Eur J Endocrinol; 1995 Apr; 132(4):479-86. PubMed ID: 7711887
[TBL] [Abstract][Full Text] [Related]
28. Dysfunction of the hypothalamic-pituitary-adrenal axis in STX1A knockout mice.
Fujiwara T; Kofuji T; Akagawa K
J Neuroendocrinol; 2011 Dec; 23(12):1222-30. PubMed ID: 21910766
[TBL] [Abstract][Full Text] [Related]
29. Gene expression of phenylethanolamine N-methyltransferase in corticotropin-releasing hormone knockout mice during stress exposure.
Kvetnansky R; Kubovcakova L; Tillinger A; Micutkova L; Krizanova O; Sabban EL
Cell Mol Neurobiol; 2006; 26(4-6):735-54. PubMed ID: 16691441
[TBL] [Abstract][Full Text] [Related]
30. Pituitary-adrenal responses to CRH and insulin hypoglycemia in patients with idiopathic GH deficiency.
Sartorio A; Morabito F; Ambrosi B
J Endocrinol Invest; 1989 Jan; 12(1):19-23. PubMed ID: 2545764
[TBL] [Abstract][Full Text] [Related]
31. Stimulation of adrenocorticotropin secretion by insulin-induced hypoglycemia in the developing rat involves arginine vasopressin but not corticotropin-releasing factor.
Muret L; Priou A; Oliver C; Grino M
Endocrinology; 1992 May; 130(5):2725-32. PubMed ID: 1315256
[TBL] [Abstract][Full Text] [Related]
32. Regulation of pituitary ACTH secretion during chronic stress.
Aguilera G
Front Neuroendocrinol; 1994 Dec; 15(4):321-50. PubMed ID: 7895891
[TBL] [Abstract][Full Text] [Related]
33. Intracerebroventricular administration of corticotrophin-releasing hormone receptor antagonists produces different effects on hypothalamic pituitary adrenal responses to novel restraint depending on the stress history of the animal.
Vining C; Iyer V; Bhatnagar S
J Neuroendocrinol; 2007 Mar; 19(3):198-207. PubMed ID: 17280593
[TBL] [Abstract][Full Text] [Related]
34. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats.
Thomas GB; Fairhall KM; Robinson IC
Endocrinology; 1997 Apr; 138(4):1585-91. PubMed ID: 9075719
[TBL] [Abstract][Full Text] [Related]
35. Hypothalamo-pituitary-adrenal axis sensitization after chronic salt loading.
Amaya F; Tanaka M; Hayashi S; Tanaka Y; Ibata Y
Neuroendocrinology; 2001 Mar; 73(3):185-93. PubMed ID: 11307037
[TBL] [Abstract][Full Text] [Related]
36. Effect of cyclooxygenase inhibitors on the CRH-induced pituitary-adrenocortical activity during crowding stress.
Bugajski J; Gadek-Michalska A; Bugajski AJ
J Physiol Pharmacol; 2003 Mar; 54(1):99-108. PubMed ID: 12674222
[TBL] [Abstract][Full Text] [Related]
37. Involvement of corticotropin-releasing hormone- and interleukin (IL)-6-dependent proopiomelanocortin induction in the anterior pituitary during hypothalamic-pituitary-adrenal axis activation by IL-1alpha.
Chida D; Imaki T; Suda T; Iwakura Y
Endocrinology; 2005 Dec; 146(12):5496-502. PubMed ID: 16141396
[TBL] [Abstract][Full Text] [Related]
38. Impaired diurnal adrenal rhythmicity restored by constant infusion of corticotropin-releasing hormone in corticotropin-releasing hormone-deficient mice.
Muglia LJ; Jacobson L; Weninger SC; Luedke CE; Bae DS; Jeong KH; Majzoub JA
J Clin Invest; 1997 Jun; 99(12):2923-9. PubMed ID: 9185516
[TBL] [Abstract][Full Text] [Related]
39. Modulation of corticotropin-releasing hormone receptor type 2 mRNA expression by CRH deficiency or stress in the mouse heart.
Pournajafi Nazarloo H; Tanaka Y; Dorobantu M; Hashimoto K
Regul Pept; 2003 Sep; 115(2):131-8. PubMed ID: 12972328
[TBL] [Abstract][Full Text] [Related]
40. Excess corticotropin releasing hormone-binding protein in the hypothalamic-pituitary-adrenal axis in transgenic mice.
Burrows HL; Nakajima M; Lesh JS; Goosens KA; Samuelson LC; Inui A; Camper SA; Seasholtz AF
J Clin Invest; 1998 Apr; 101(7):1439-47. PubMed ID: 9525987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
